Related Experiment Videos
Purification of recombinant HIV-1 protease
N Margolin1, A Dee, M Lai
1Lilly Research Laboratories, Indianapolis, IN 46285.
Preparative Biochemistry
|January 1, 1991
Summary
This study details a purification method for recombinant human immunodeficiency virus type 1 (HIV-1) protease using Escherichia coli extracts. The developed protocol yields homogeneous protease, crucial for antiviral drug development.
Area of Science:
- Biochemistry
- Molecular Biology
- Virology
Background:
- Recombinant human immunodeficiency virus type 1 (HIV-1) protease is a key target for antiviral therapies.
- Efficient purification of this enzyme from expression systems like Escherichia coli is essential for structural and functional studies.
Purpose of the Study:
- To develop and describe a robust purification strategy for recombinant HIV-1 protease expressed in Escherichia coli.
- To obtain homogeneous HIV-1 protease suitable for further biochemical and structural investigations.
Main Methods:
- Utilized a multi-step chromatographic approach including QAE-Sepharose anion exchange, hexyl agarose hydrophobic interaction, MonoS cation exchange, and Superose 6 size exclusion chromatography.
- Purification was performed on soluble extracts from Escherichia coli expressing the recombinant protease.
Main Results:
- Successfully isolated approximately 100 micrograms of recombinant HIV-1 protease from 18 grams of E. coli paste.
- SDS-PAGE analysis confirmed the homogeneity of the purified protein, indicated by a single band on a silver-stained gel.
Conclusions:
- The described purification method is effective for obtaining homogeneous recombinant HIV-1 protease.
- This protocol provides a reliable source of purified enzyme for research into HIV-1 replication and drug discovery.